相似文献
1
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.
Trends Cell Biol. 2015 Nov;25(11):675-686. doi: 10.1016/j.tcb.2015.07.012. Epub 2015 Oct 1.
2
The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Curr Pharm Des. 2015;21(10):1279-91. doi: 10.2174/1381612821666141211115611.
3
Involvement of partial EMT in cancer progression.
J Biochem. 2018 Oct 1;164(4):257-264. doi: 10.1093/jb/mvy047.
4
Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
Cells. 2020 Jan 15;9(1):217. doi: 10.3390/cells9010217.
5
HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
Oncotarget. 2017 Feb 7;8(6):9535-9545. doi: 10.18632/oncotarget.14484.
6
TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Curr Opin Oncol. 2013 Jan;25(1):76-84. doi: 10.1097/CCO.0b013e32835b6371.
7
Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
Stem Cells. 2016 Aug;34(8):1997-2007. doi: 10.1002/stem.2406. Epub 2016 Jun 20.
8
Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Mol Oncol. 2017 Jul;11(7):792-804. doi: 10.1002/1878-0261.12096. Epub 2017 Jun 26.
9
Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.
Cell Adh Migr. 2015;9(4):265-76. doi: 10.4161/19336918.2014.972761. Epub 2014 Oct 16.
10
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
J Hematol Oncol. 2016 Aug 30;9(1):74. doi: 10.1186/s13045-016-0307-9.
引用本文的文献
1
Interplay of oxidative stress and antioxidant mechanisms in cancer development and progression.
Arch Toxicol. 2025 Sep 4. doi: 10.1007/s00204-025-04146-5.
2
Perspectives on integrating artificial intelligence and single-cell omics for cellular plasticity research.
Quant Biol. 2025 Dec;13(4). doi: 10.1002/qub2.70004. Epub 2025 Apr 24.
3
Inorganic Polyphosphate Triggers NLRP3 Inflammasome and Promotes the Epithelial-to-Mesenchymal Transition and Migration of Colorectal Cancer Cells Through TRPM8 Receptor.
Int J Mol Sci. 2025 Aug 11;26(16):7743. doi: 10.3390/ijms26167743.
4
Multi-Omic Characterization of Epithelial-Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma.
Cells. 2025 Aug 10;14(16):1233. doi: 10.3390/cells14161233.
5
The role of SOX transcription factors in prostate cancer: Focusing on SOX2.
Genes Dis. 2025 May 21;12(6):101692. doi: 10.1016/j.gendis.2025.101692. eCollection 2025 Nov.
6
Metastatic heterogeneity in pancreatic cancer: mechanisms and opportunities for targeted intervention.
J Clin Invest. 2025 Jul 15;135(14). doi: 10.1172/JCI191943.
7
A patient-derived organoid model captures fetal-like plasticity in colorectal cancer.
Cell Res. 2025 Jul 4. doi: 10.1038/s41422-025-01139-y.
8
The Role and Function of Non-Coding RNAs in Cholangiocarcinoma Invasiveness.
Biomedicines. 2025 Jun 3;13(6):1369. doi: 10.3390/biomedicines13061369.
9
Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated progression from pancreatic intraepithelial neoplasia to invasive pancreatic cancer.
Cancer Cell Int. 2025 Jun 10;25(1):208. doi: 10.1186/s12935-025-03810-1.
10
Cisplatin palbociclib combination differentially modulates PTEN AKT signaling via Hsp90 in hepatocellular carcinoma cells.
Sci Rep. 2025 Jun 2;15(1):19319. doi: 10.1038/s41598-025-04008-1.
本文引用的文献
1
Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation.
Cell Rep. 2015 Jan 13;10(2):131-9. doi: 10.1016/j.celrep.2014.12.032. Epub 2015 Jan 8.
2
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
Nat Commun. 2014 Oct 28;5:5241. doi: 10.1038/ncomms6241.
3
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.
Nat Cell Biol. 2014 Nov;16(11):1105-17. doi: 10.1038/ncb3041. Epub 2014 Sep 28.
4
Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition.
Cell. 2014 Aug 28;158(5):1094-1109. doi: 10.1016/j.cell.2014.07.032.
5
Transient SNAIL1 expression is necessary for metastatic competence in breast cancer.
Cancer Res. 2014 Nov 1;74(21):6330-40. doi: 10.1158/0008-5472.CAN-14-0923. Epub 2014 Aug 27.
6
A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.
Breast Cancer Res. 2014 Jul 25;16(4):407. doi: 10.1186/s13058-014-0407-9.
7
Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.
Oncogene. 2015 Apr 23;34(17):2261-71. doi: 10.1038/onc.2014.151. Epub 2014 Jun 16.
8
A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.
Cancer Cell. 2014 May 12;25(5):605-20. doi: 10.1016/j.ccr.2014.03.021.
9
Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.
Breast Cancer Res Treat. 2014 Jun;145(2):339-48. doi: 10.1007/s10549-014-2927-5. Epub 2014 Apr 26.
10
TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.
Cell Rep. 2013 Dec 12;5(5):1228-42. doi: 10.1016/j.celrep.2013.11.014.
Zotero 插件